SB 525334
Tocris Bioscience, part of Bio-Techne | Catalog # 3211
Selective inhibitor of TGF-βRI
Key Product Details
Description
Selective inhibitor of TGF-βRI
Product Description
SB 525334 is a selective inhibitor of transforming growth factor-β receptor I (ALK5, TGF-βRI) (IC50 = 14.3 nM). Inhibits TGF-β1-induced smad2/3 nuclear localization and TGF-βRI-induced mRNA expression in kidney cells. Attenuates bleomycin-induced pulmonary fibrosis.Licensing Information
Sold with the permission of GlaxoSmithKlineProduct Specifications
Molecular Weight
343.42
Formula
C21H21N5
Storage
Store at -20°C
Purity
≥97% (HPLC)
Chemical Name
6-[2-(1,1-Dimethylethyl)-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline
CAS Number
356559-20-1
PubChem ID
9967941
InChI Key
DKPQHFZUICCZHF-UHFFFAOYSA-N
SMILES
CC1=NC(C4=C(NC(C(C)(C)C)=N4)C2=CC=C(N=CC=N3)C3=C2)=CC=C1
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 34.34 | 100 |
Preparing Stock Solutions
for SB 525334
The following data is based on the product molecular weight 343.42
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 2.91 mL | 14.56 mL | 29.12 mL |
| 5 mM | 0.58 mL | 2.91 mL | 5.82 mL |
| 10 mM | 0.29 mL | 1.46 mL | 2.91 mL |
| 50 mM | 0.06 mL | 0.29 mL | 0.58 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Higashiyama Inhibition of AVNreceptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis Exp.Mol.Pathol. 2007 PMID: 17274978
- Laping Tumor-specific efficacy of transforming growth factor-βRI inhibition in eker rats. Clin.Cancer Res. 2007 PMID: 17505012
- Grygielko Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-β type I receptor kinase in puromycin-induced nephritis. J.Pharmacol.Exp.Ther. 2005 PMID: 15769863
Product Specific Notices for SB 525334
For research use only
Loading...
Loading...